President of Amarillo cardiovascular andThoracic surgery
Thoracic Surgery
Dr. Masoud A. Alzeerah, MD
Masoud Alzeerah practices Thoracic Surgery. He went to medical school at Tehran University of Medical Sciences School of Medicine. He has 5 awards "Texas Tech University Health science center Faculty teaching award", "Clinical Assistant professor at TexasTech university, department of surgery", "CMS Meaningful Use Stage 1 Certification", "FRCSC" and "Fellow (FACS)". Masoud Alzeerah is a published physician as well. He has 2 publications published. The latest was: Transmyocardial laser therapy: a strategic approach. Dr. Masoud A. Alzeerah is registered with Medicare and accepts Medicare payments.
Publications
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Aortic Repair, Open or Repair of Arterial Aneurysm, Open
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- View All
Doctors Specialties
Accepted Insurances
Awards
- Texas Tech University Health science center Faculty teaching award
- Clinical Assistant professor at TexasTech university, department of surgery
- CMS Meaningful Use Stage 1 Certification
- FRCSC
- Fellow (FACS)
Education
-
Tehran University of Medical Sciences School of Medicine
Drug Facts
NPI NUMBER |
|
1265438683 |
NPPES Provider LastName |
|
ALZEERAH |
NPPES Provider FirstName |
|
MASOUD |
NPPES Provider ZIPCode |
|
791061768 |
NPPES Provider State |
|
TX |
Specialty Description |
|
Thoracic Surgery |
Total Claim Count |
|
579.0 |
Distinct Opioid Count |
|
2.0 |
Opioid Claim Count |
|
92.0 |
Percent Opioid Claims |
|
15.89 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1265438683 |
Last Name Of The Provider |
ALZEERAH |
First Name Of The Provider |
MASOUD |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog